Search by category - Any -Regulated informationInside informationNon-regulated information Search by year - Any -2024202320222021202020192018201720162015 31 July 2021 Fire Incident at Biocartis Warehouse in Mechelen, Belgium Non-regulated information 4 June 2021 Results of the Extraordinary Shareholders’ Meeting held on 4 June 2021 Regulated information 17 May 2021 Invitation to the Extraordinary Shareholders’ Meeting Regulated information 14 May 2021 Results of the Shareholders’ Meetings held on 14 May 2021 Regulated information 11 May 2021 Biocartis Receives EUR 1.4m Grant to Support Development of New Idylla™ Technology to Unlock Potential in Molecular Surveillance Non-regulated information 4 May 2021 Biocartis Announces New Collaboration with AstraZeneca to Expand Availability of Idylla™ EGFR Biomarker Testing Among Patients with Lung Cancer Non-regulated information 22 April 2021 BIOCARTIS Q1 2021 BUSINESS UPDATE Regulated information 22 April 2021 Biocartis and SkylineDx Sign Collaboration to Develop the Merlin Assay, a Test Predicting Risk for Nodal Metastasis in Melanoma, on Idylla™ Inside information Regulated information 20 April 2021 Biocartis Announces US FDA 510(k) submission of its Idylla™ MSI Test Non-regulated information 13 April 2021 Invitation to the Annual and Extraordinary Shareholders’ Meetings Regulated information Pagination First page « First Previous page ‹‹ … Page 7 Page 8 Page 9 Page 10 Current page 11 Page 12 Page 13 Page 14 Page 15 … Next page ›› Last page Last »